Latest News
-
Co-ordinated COVID-19 Research Response
Posted on:
Kolling Institute researchers are a key part of a new Northern Sydney Local Health District COVID-19 Clinical Research Group. All major specialist disciplines are represented in the group, taking advantage of the breadth of knowledge across the health campus. Kolling researcher Associate Professor Clifton-Bligh said we formed the group because we saw a clear need
Primary Research Area/s:
-
Important national COVID-19 study
Posted on:
For many people with heart disease there’s an increased level of anxiety around the implications of COVID-19, but it’s hoped a new study led by Royal North Shore Hospital will guide future treatment and improve health outcomes. Head of cardiology Professor Ravinay Bhindi has launched the AUS-COVID study, which will involve more than 800 patients
Primary Research Area/s:
-
Multiple medications cause frailty, but this can be reversed
Posted on:
A world-first study by a team from the Kolling Institute may inform the future use of multiple medications by older people, minimising adverse impacts including frailty. The longitudinal research is the first preclinical study to demonstrate that multiple medications can impair function in old age, and that stopping some can reduce harm. Research lead, Professor
Primary Research Area/s:
-
Celebrating 100 years of research excellence
Posted on:
2020 is an important year for the Kolling Institute as it marks the 100 year anniversary of the research organisation. As the longest-running medical research institute in New South Wales, the Kolling has a very rich history. Originally named the Institute of Pathological Research of NSW, the organisation was established in a cottage within the
Primary Research Area/s:
-
New funding to help reduce Australia’s bowel cancer rates
Posted on:
Professor Mark Molloy’s ground-breaking bowel cancer research has received a boost, with the Cancer Council NSW awarding the Kolling Institute researcher a three-year $450,000 grant. Professor Molloy has welcomed the funding, saying bowel cancer claims more lives each year than breast, prostate or skin cancer. “It is now Australia’s second biggest cancer killer, with more
Primary Research Area/s:
-
-
International focus on our ovarian cancer research
Posted on:
In an exciting breakthrough, researchers from the Kolling Institute’s Bill Walsh Lab have identified new genes involved in the spread of ovarian cancer. Tragically, it is the deadliest female cancer, claiming more than 900 lives in Australia each year. Most women are diagnosed relatively late, when the cancer has spread, significantly reducing their chances of
Primary Research Area/s:
-
Home grown ideas place physio in patients’ hands
Posted on:
New research is testing a new way to meet the rapidly growing demand for physiotherapy in our public hospitals. A clinical trial at four hospitals, including Hornsby and Royal North Shore, is studying whether some patients can successfully undertake physiotherapy exercises at home and still experience the same benefit provided by attending a hospital clinic.
Primary Research Area/s:
-
Common medication may lower risk of “heartbreak”
Posted on:
RNSH cardiologist Professor Geoffrey Tofler has led a world-first study which found that common medications can reduce the risk of heart attack in those grieving a loved one. Professor Tofler said while most people gradually adjust to the loss of a loved one, there is an increase in heart attacks and death among bereaved people,
Primary Research Area/s:
-
Research spotlight on specialist NICU team
Posted on:
Celebrity couple Hayden James and Jennifer Luby shared their emotional journey following the premature birth of their son during the inaugural Women and Babies Research team seminar at the Kolling. Hayden, an award winning Australian musician and DJ, and his wife Jennifer, a Sydney-based artist, spent 87 days in the Neonatal Intensive Care Unit at
Primary Research Area/s:
